Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].

Buti M.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:32-8. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100229
2.

[Clinical management of patients with chronic hepatitis B virus infection].

Rodríguez M, González-Diéguez ML.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:56-65. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100232
3.

[Interferon in hepatitis B].

García Buey L, González Mateos F, Moreno Otero R.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:19-31. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100228
4.

[Entecavir].

Calleja JL, Peñas B.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:39-48. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100230
5.

[Pharmacological agents for the treatment of chronic hepatitis B].

Sánchez-Tapias JM.

Gastroenterol Hepatol. 2008 Mar;31(3):120-8. Review. Spanish. No abstract available.

PMID:
18341843
6.

[Hepatitis B in patients with HIV infection].

Barreiro P, Martín-Carbonero L, García-Samaniego J.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:71-9. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100234
7.

Pharmacotherapy of hepatitis B infection: a brief review.

Quan DJ.

Nephrol Nurs J. 2008 Sep-Oct;35(5):507-10, 534. Review.

PMID:
18856082
8.

Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.

Chien RN, Liaw YF.

Best Pract Res Clin Gastroenterol. 2008;22(6):1081-92. doi: 10.1016/j.bpg.2008.11.003. Review.

PMID:
19187868
9.

Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.

Reijnders JG, Deterding K, Petersen J, Zoulim F, Santantonio T, Buti M, van Bömmel F, Hansen BE, Wedemeyer H, Janssen HL; VIRGIL Surveillance Study Group.

J Hepatol. 2010 Apr;52(4):493-500. doi: 10.1016/j.jhep.2010.01.012. Epub 2010 Feb 4.

PMID:
20185191
10.

[Resistance in hepatitis B virus].

Sheldon J, Sarmento E Castro R, Soriano V.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:49-55. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100231
11.

Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.

Singal AK, Fontana RJ.

Aliment Pharmacol Ther. 2012 Mar;35(6):674-89. doi: 10.1111/j.1365-2036.2011.04990.x. Epub 2012 Jan 19.

12.

[The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].

Lin Q, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):722-5. Chinese. No abstract available.

PMID:
19874684
13.

Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.

Yang JX, Liu BM, Li XG, Yan CH, Xu J, Sun XW, Wang YH, Jiao XJ, Yan L, Dong JP, Hou CS, Abuduheilili X, Li T, Zhuang H.

Antivir Ther. 2010;15(8):1171-8. doi: 10.3851/IMP1677.

PMID:
21149924
14.

Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.

Lee JM, Park JY, Kim do Y, Nguyen T, Hong SP, Kim SO, Chon CY, Han KH, Ahn SH.

Antivir Ther. 2010;15(2):235-41. doi: 10.3851/IMP1510.

PMID:
20386079
15.

Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.

Zhu Y, Curtis M, Qi X, Miller MD, Borroto-Esoda K.

Antivir Chem Chemother. 2009;19(4):165-76.

PMID:
19374144
16.

[A study on the treatment of chronic hepatitis B with YMDD mutation].

Qiu YW, Jiang XH, Huang LH, Hu TH, Ding H, Jiang YM, Dai YX, Zhou M.

Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):171-4. Chinese.

PMID:
19335977
17.

Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.

Nguyen MH, Keeffe EB.

J Viral Hepat. 2009 Mar;16(3):149-55. doi: 10.1111/j.1365-2893.2009.01078.x. Review.

PMID:
19236641
18.

Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

Buster EH, Schalm SW, Janssen HL.

Best Pract Res Clin Gastroenterol. 2008;22(6):1093-108. doi: 10.1016/j.bpg.2008.11.007. Review.

PMID:
19187869
19.

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

Peters MG, Hann Hw Hw, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df Df, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL.

Gastroenterology. 2004 Jan;126(1):91-101.

PMID:
14699491
20.

New drugs for chronic hepatitis B: a review.

Palumbo E.

Am J Ther. 2008 Mar-Apr;15(2):167-72. doi: 10.1097/MJT.0b013e318155a191. Review.

PMID:
18356637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk